We started Modern Bio on a simple premise: people who research GLP-1 compounds deserve more than marketing copy. They deserve the actual science — mechanisms, trial data, pharmacokinetics, and an honest account of what these molecules do and don't do. To hold ourselves to that standard, we're glad to share that our science content is now written and reviewed by Dr. David Chen, MD, PhD.
Who is Dr. Chen?
Dr. Chen is a board-certified endocrinologist specializing in obesity medicine, with 15 years of clinical experience. Over that time he has treated more than 800 patients with pharmaceutical weight-loss interventions, including semaglutide, tirzepatide, and retatrutide — the same triple-agonist class that draws so much research interest today.
He completed his endocrinology fellowship at Massachusetts General Hospital and maintains an active clinical practice at Metropolitan Endocrinology Associates. Alongside that practice, he serves as an investigator on clinical trials of GLP-1 receptor agonists and other metabolic optimization compounds — which means the explainers on this site are informed not just by the published literature, but by firsthand experience designing and running the studies that produce it.
Why this matters for what you read here
Dr. Chen has published research on metabolic adaptation after weight loss and sits on the medical advisory board of the Obesity Medicine Association. His clinical philosophy is one we share: an evidence-based, realistic approach that acknowledges both the power and the limitations of pharmaceutical interventions. No miracle framing, no hand-waving — just what the data supports.
Practically, this means a few things for the content on Modern Bio:
- Accuracy first. Mechanism explainers, dosing math, and trial summaries are written and reviewed against the primary literature and clinical experience.
- Honest limitations. Where the evidence is thin, preliminary, or contested, we say so rather than papering over it.
- Research framing. Everything here remains oriented toward understanding the compounds, consistent with our research-use-only positioning.
You can read more about Dr. Chen's background on his author page, and you'll see his byline on the science articles he authors and reviews going forward. We think it makes the work better, and we're glad to have him.